Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study.
Andreyev HJN, Matthews J, Adams C, Gothard L, Lucy C, Tovey H, Boyle S, Anbalagan S, Musallam A, Yarnold J, Abraham D, Bliss J, Abdi BA, Taylor A, Hauer-Jensen M. Andreyev HJN, et al. Radiother Oncol. 2022 Mar;168:130-137. doi: 10.1016/j.radonc.2022.01.024. Epub 2022 Jan 29. Radiother Oncol. 2022. PMID: 35093409 Clinical Trial.
Defining pelvic-radiation disease for the survivorship era.
Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M. Andreyev HJ, et al. Lancet Oncol. 2010 Apr;11(4):310-2. doi: 10.1016/S1470-2045(10)70026-7. Epub 2010 Feb 8. Lancet Oncol. 2010. PMID: 20149738 No abstract available.
Radiation enteropathy--pathogenesis, treatment and prevention.
Hauer-Jensen M, Denham JW, Andreyev HJ. Hauer-Jensen M, et al. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):470-9. doi: 10.1038/nrgastro.2014.46. Epub 2014 Apr 1. Nat Rev Gastroenterol Hepatol. 2014. PMID: 24686268 Free PMC article. Review.
Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.
Wedlake L, Shaw C, McNair H, Lalji A, Mohammed K, Klopper T, Allan L, Tait D, Hawkins M, Somaiah N, Lalondrelle S, Taylor A, VanAs N, Stewart A, Essapen S, Gage H, Whelan K, Andreyev HJN. Wedlake L, et al. Among authors: andreyev hjn. Am J Clin Nutr. 2017 Sep;106(3):849-857. doi: 10.3945/ajcn.116.150565. Epub 2017 Jul 5. Am J Clin Nutr. 2017. PMID: 28679552 Free article. Clinical Trial.
The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.
Andreyev HJN, Lalji A, Mohammed K, Muls ACG, Watkins D, Rao S, Starling N, Chau I, Cruse S, Pitkaaho V, Matthews J, Caley L, Pittordou V, Adams C, Wedlake L. Andreyev HJN, et al. Support Care Cancer. 2021 Mar;29(3):1443-1453. doi: 10.1007/s00520-020-05610-x. Epub 2020 Jul 16. Support Care Cancer. 2021. PMID: 32676853 Free PMC article.
A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
Khalid U, McGough C, Hackett C, Blake P, Harrington KJ, Khoo VS, Tait D, Norman AR, Andreyev HJ. Khalid U, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1432-41. doi: 10.1016/j.ijrobp.2005.10.007. Int J Radiat Oncol Biol Phys. 2006. PMID: 16580497
86 results